- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, October 13, 2017
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press
An article on the role of mobile clinics in delivering preventive care from The Pew Charitable Trusts highlighted a study published by The American Journal of Managed Care® (AJMC®) as a reference. “Mobile Health Clinics in the Era of Reform,” published by AJMC® in 2014, found that Family Van patients who were diagnosed with high blood pressure had significantly lower blood pressure on follow-up visits.
A study published in AJMC® was cited in a patient responsibility news article from Patient EngagementHIT. Research on “The Relationship Between Adherence and Total Spending Among Medicare Beneficiaries With Type 2 Diabetes,” published by AJMC® in April, found that although cost sharing saves Medicare money on pharmaceutical expenses, these savings are likely negated by low medication adherence and eventual health complications.
Healio cited AJMC® as a source for its study on Pharmacogenomics and Psychiatric Clinical Care. A study published by AJMC® in 2014 found evidence that suggests genetic testing for psychiatric illness can be effective for decreasing healthcare costs. The study, “Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings,” also found that utilizing pharmacogenetics testing in everyday psychiatric clinical practice can lead to improved patient adherence.
POLITICO’s weekly briefing on pharmaceutical policy news Tuesday included a study published by AJMC® on black box warnings. The article, “The Associated Between FDA Black Box Warnings and Medicare Formulary Coverage Changes,” focused on a study that found that for most drugs with black box warnings, the strongest action the FDA can take, formulary restrictions remained unchanged.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
